REGN
REGENERON PHARMACEUTICALS, INC.Data updated: 2026-04-21 · Current price: $698.25
Composite Score: 40
PASS
Score: 40 / 100
Insufficient margin of safety — pass on this opportunity
Profitability
0
Growth
0
Valuation
33
Moat
0
Stability
100
Business Quality
ROE · Gross Margin · Revenue Growth
ROE
14.4%
Quality threshold: > 15%
Gross Margin
24.9%
Quality threshold: > 40%
Rev. Growth (5yr)
0.0%
Quality threshold: > 5%
5-Year ROE: 14.4% → 15.0% → 15.2% → 19.1% → 43.0%|5-Year Gross Margin: 24.9% → 28.1% → 30.9% → 38.9% → 55.7%
Financial Strength
Debt Ratio · Free Cash Flow · Current Ratio
Debt / Equity
0.3
Quality threshold: < 0.5
FCF (5yr avg)
5.2B $
Quality threshold: > 0
Current Ratio
4.36x
Quality threshold: > 1.5
FCF Trend (B USD)
$5.0B2022
$4.4B2023
$4.6B2024
$5.0B2025
$7.1B2026
Valuation
Intrinsic Value · Margin of Safety
Owner Earnings
$5.0B
Net Income + D&A - CapEx
Current Price
$698.25
Source: Alpha Vantage
💡 Valuation Note: Intrinsic value based on DCF model, adjustable above. Visit the DCF Calculator for full three-stage valuation.
Complete Your Analysis
"Price is what you pay. Value is what you get."
— Warren Buffett